Treatment of Eustachian Tube Dysfunction (ETD) and Facial Pain With Combined Acoustic Vibration and Oscillating Expiratory Pressure

Eustachian Tube Dysfunction Clinical Trial

Official title:

Treatment of Eustachian Tube Dysfunction (ETD) and Facial Pain With Combined Acoustic Vibration and Oscillating Expiratory Pressure

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT04404036
• Other study ID #: PRO#00097842
• Status: Recruiting
• Phase: N/A
• Start date: August 11, 2020
• Est. completion date: July 1, 2025

Study information

• Verified date: July 2023
• Source: Medical University of South Carolina
• Contact: Matthew Germroth
• Phone: 8438761166
• Email: germroth[@]musc.edu
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This study aims to test the safety, efficacy and potential mechanism of action of the SinuSonic device on adults with eustachian tube dysfunction (ETD) or facial pain/pressure. SinuSonic is a medical device that utilizes sound and pressure combined with normal breathing. The study will have 3 aims. Aim 1 will examine healthy controls with no signs of upper respiratory infection, inflammation, or ETD to determine if exhaled nasal Nitric Oxide is increased. Nitric Oxide is a compound in the body that acts as a blood vessel relaxant. Acoustic energy (humming) has been shown to increase nasal Nitric Oxide dramatically, thus equalization of gas pressures between the middle ear, the paranasal sinuses and the nasal cavity may very well explain any efficacy noted. Aim 2 will be performed to examine therapeutic efficacy for ETD. Aim 3 will be performed to examine therapeutic efficacy for sinus pain/pressure.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 70
• Est. completion date: July 1, 2025
• Est. primary completion date: July 1, 2025
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

AIM 1

Inclusion Criteria:

• Adults 18 years or older with no symptoms of URI, ETD or other ENT conditions

Exclusion Criteria:

• Sinonasal or ear surgery within last 3 months (including balloon ET dilation)

• Any ENT condition that may impact upper airway to include sinusitis, otitis, or allergies

• Upper respiratory illness within last 2 weeks

• Topical decongestant use in last week

• Current nasal crusting or ulceration on rhinoscopy

• History of severe nose bleeding within last 3 months

• Known pregnancy

• Allergic sensitivity to silicone or any other component of device

• Inability to read and understand English

• Inability to perform treatment due to underlying medical condition

AIM 2

Inclusion:

• Adults 18 years or older with diagnosis of ETD by an otolaryngologist

• =6 months of symptoms duration

• =3 ETD symptoms (ear pressure, feeling that ears are clogged, cracking/popping of ears, muffled hearing, tinnitus)

• ETDQ-7 score = 3

• Audiogram within the last year

Exclusion:

• Sinonasal or ear surgery within last 3 months (including balloon ET dilation)

• Indwelling ear tubes

• Tympanic membrane perforation

• Hx of cholesteatoma, mastoidectomy, tympanoplasty, or ossicular chain reconstruction

• Patulous ET

• Hx of Meniere's disease

• Moderate or severe nasal valve collapse

• Grade 3-4 polyps

• Upper respiratory illness within last 2 weeks

• Topical decongestant use in last week

• Current nasal crusting or ulceration on rhinoscopy

• History of severe nose bleeding within last 3 months

• Known pregnancy

• Allergic sensitivity to silicone or any other component of device

• Inability to read and understand English

• Inability to perform treatment due to underlying medical condition

AIM 3

Inclusion:

• Adults 18 years or older who complain of facial pain or pressure

• =3 months of symptoms duration (can be intermittent)

• Pain/pressure VAS score = 5

Exclusion:

• Sinonasal surgery within the last 3 months

• Grade 3-4 polyps

• Upper respiratory illness within last 2 weeks

• Topical decongestant use in last week

• Current nasal crusting or ulceration on rhinoscopy

• History of severe nose bleeding within last 3 months

• Known pregnancy

• Allergic sensitivity to silicone or any other component of device

• Inability to read and understand English

• Inability to perform treatment due to underlying medical condition

Related Conditions & MeSH terms

• Eustachian Tube Dysfunction
• Facial Pain
• Facies

Intervention

Device:
• SinuSonic Device
A medical device that utilizes sound and pressure combined with normal breathing to relieve nasal congestion.

Locations

Country	Name	City	State
United States	Sinus Center - Medical Univesity of South Carolina	Charleston	South Carolina

Sponsors (1)

Lead Sponsor	Collaborator
Medical University of South Carolina

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Symptoms severity according to an ETD Visual Analogue Scale	Symptoms severity will be assessed on Visual Analogue Scale (on the scale of 1-10). Visual Analogue Scale is a psychometric response scale which can be used in questionnaires. It is a measurement instrument for subjective characteristics or attitudes that cannot be directly measured.	6 Weeks
Primary	Symptoms severity according to a Pain/pressure Visual Analogue Scale	Symptoms severity will be assessed on Visual Analogue Scale (on the scale of 1-10). Visual Analogue Scale is a psychometric response scale which can be used in questionnaires. It is a measurement instrument for subjective characteristics or attitudes that cannot be directly measured.	2 to 4 Weeks
Secondary	McGill Pain Questionnaire - Short Form	The MPQ-SF is a well-validated pain measure that permits separation of the sensory and affective components of pain, which are averaged to compute a total score. The scale ranges from 0-10 (0=no pain, 10=the most pain).	2 to 4 Weeks
Secondary	Worst Pain Using the Modified Brief Pain Inventory - Short Form (m-BPI-sf)	Modified Brief Pain Inventory - Short Form (m-BPI-sf): participant rated 11-point Likert rating scale ranged from 0 (no pain) to 10 (worst pain imaginable).	2 to 4 Weeks
Secondary	Mean Change in Overall ETDQ-7 Score	Mean change from baseline to 6 weeks in the overall ETDQ-7 score. The 7-item Eustachian Tube Dysfunction Questionnaire (ETDQ-7) is a validated patient-reported tool measuring ETD symptoms and severity. The 7 items are: pressure in the ears, pain in the ears, a feeling that the participant's ears are clogged or underwater, ear symptoms when the participants have a cold or sinusitis, cracking or popping sounds in the ear, ringing in the ears, and a feeling that the participant's hearing is muffled. Each item is rated from 1 (no problem) to 7 (severe problem) and a mean is calculated for the overall score (range from 1-7). Scores of 1-2 indicate no to mild symptoms, 3-5 moderate, and 6-7 severe symptoms.	6 Weeks